ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.567
+0.042 (8.04%)
Nov 20, 2024, 4:00 PM EST - Market closed
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $6.80 million as of November 21, 2024. Its market cap has increased by 61.92% in one year.
Market Cap
6.80M
Enterprise Value
8.54M
1-Year Change
61.92%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $6.80M, a decrease of -91.45%. That is a compound annual growth rate of -52.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 6.80M | -19.05% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evoke Pharma | 7.23M |
| BioCardia | 7.11M |
| Plus Therapeutics | 7.02M |
| Edesa Biotech | 6.86M |
| Brainstorm Cell Therapeutics | 6.70M |
| ATI Physical Therapy | 6.69M |
| Addex Therapeutics | 6.64M |
| GT Biopharma | 6.55M |